Acadia Healthcare Company, Inc. (ACHC)
USD 23.31
(2.33%)
USD 23.31
(2.33%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 2.92 Billion USD | 12.2% |
| 2022 | 2.61 Billion USD | 12.79% |
| 2021 | 2.31 Billion USD | 10.74% |
| 2020 | 2.08 Billion USD | -32.74% |
| 2019 | 3.1 Billion USD | 3.15% |
| 2018 | 3.01 Billion USD | 6.21% |
| 2017 | 2.83 Billion USD | 0.9% |
| 2016 | 2.81 Billion USD | 56.64% |
| 2015 | 1.79 Billion USD | 78.63% |
| 2014 | 1 Billion USD | 40.82% |
| 2013 | 713.4 Million USD | 75.09% |
| 2012 | 407.46 Million USD | 84.06% |
| 2011 | 221.37 Million USD | 256.46% |
| 2010 | 62.1 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q3 | 815.63 Million USD | 2.46% |
| 2024 Q1 | 768.05 Million USD | 3.4% |
| 2024 Q2 | 796.04 Million USD | 3.64% |
| 2023 Q3 | 750.33 Million USD | 2.6% |
| 2023 Q4 | 742.8 Million USD | -1.0% |
| 2023 Q2 | 731.33 Million USD | 3.84% |
| 2023 FY | 2.92 Billion USD | 12.2% |
| 2023 Q1 | 704.26 Million USD | 4.29% |
| 2022 Q3 | 666.73 Million USD | 2.3% |
| 2022 Q1 | 616.65 Million USD | 3.9% |
| 2022 Q4 | 675.29 Million USD | 1.28% |
| 2022 FY | 2.61 Billion USD | 12.79% |
| 2022 Q2 | 651.71 Million USD | 5.69% |
| 2021 Q2 | 582.15 Million USD | 5.62% |
| 2021 Q4 | 593.48 Million USD | 1.01% |
| 2021 Q3 | 587.55 Million USD | 0.93% |
| 2021 Q1 | 551.19 Million USD | 1.83% |
| 2021 FY | 2.31 Billion USD | 10.74% |
| 2020 Q1 | 782.81 Million USD | 0.33% |
| 2020 FY | 2.08 Billion USD | -32.74% |
| 2020 Q2 | 750.31 Million USD | -4.15% |
| 2020 Q3 | 833.3 Million USD | 11.06% |
| 2020 Q4 | 541.27 Million USD | -35.04% |
| 2019 FY | 3.1 Billion USD | 3.15% |
| 2019 Q2 | 789.36 Million USD | 3.78% |
| 2019 Q3 | 777.25 Million USD | -1.53% |
| 2019 Q4 | 780.23 Million USD | 0.38% |
| 2019 Q1 | 760.61 Million USD | 2.3% |
| 2018 FY | 3.01 Billion USD | 6.21% |
| 2018 Q4 | 743.54 Million USD | -2.28% |
| 2018 Q3 | 760.91 Million USD | -0.63% |
| 2018 Q2 | 765.73 Million USD | 3.17% |
| 2018 Q1 | 742.24 Million USD | 2.45% |
| 2017 Q4 | 724.51 Million USD | 1.09% |
| 2017 Q1 | 679.19 Million USD | -3.37% |
| 2017 FY | 2.83 Billion USD | 0.9% |
| 2017 Q2 | 715.89 Million USD | 5.4% |
| 2017 Q3 | 716.71 Million USD | 0.11% |
| 2016 FY | 2.81 Billion USD | 56.64% |
| 2016 Q3 | 734.66 Million USD | -2.89% |
| 2016 Q1 | 616.81 Million USD | 24.53% |
| 2016 Q2 | 756.54 Million USD | 22.65% |
| 2016 Q4 | 702.88 Million USD | -4.33% |
| 2015 FY | 1.79 Billion USD | 78.63% |
| 2015 Q4 | 495.31 Million USD | 3.25% |
| 2015 Q3 | 479.73 Million USD | 5.75% |
| 2015 Q2 | 453.66 Million USD | 24.02% |
| 2015 Q1 | 365.78 Million USD | 24.04% |
| 2014 Q4 | 294.9 Million USD | 0.14% |
| 2014 Q2 | 213.8 Million USD | 6.15% |
| 2014 Q3 | 294.47 Million USD | 37.73% |
| 2014 Q1 | 201.41 Million USD | 6.01% |
| 2014 FY | 1 Billion USD | 40.82% |
| 2013 Q4 | 189.99 Million USD | 2.87% |
| 2013 Q1 | 161.21 Million USD | 41.1% |
| 2013 Q2 | 177.49 Million USD | 10.1% |
| 2013 FY | 713.4 Million USD | 75.09% |
| 2013 Q3 | 184.7 Million USD | 4.06% |
| 2012 Q2 | 100.53 Million USD | 10.11% |
| 2012 Q3 | 103.11 Million USD | 2.57% |
| 2012 Q1 | 91.29 Million USD | 21.16% |
| 2012 Q4 | 114.25 Million USD | 10.8% |
| 2012 FY | 407.46 Million USD | 84.06% |
| 2011 Q4 | 75.35 Million USD | 19.5% |
| 2011 Q2 | 63.57 Million USD | 277.39% |
| 2011 FY | 221.37 Million USD | 256.46% |
| 2011 Q1 | 16.84 Million USD | 22.44% |
| 2011 Q3 | 63.05 Million USD | -0.81% |
| 2010 Q4 | 13.75 Million USD | -13.31% |
| 2010 Q3 | 15.87 Million USD | 0.0% |
| 2010 FY | 62.1 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Addus HomeCare Corporation | 1.05 Billion USD | -176.648% |
| AirSculpt Technologies, Inc. | 195.91 Million USD | -1394.887% |
| Amedisys, Inc. | 2.23 Billion USD | -30.959% |
| Astrana Health, Inc. | 1.38 Billion USD | -111.208% |
| Aveanna Healthcare Holdings Inc. | 1.89 Billion USD | -54.534% |
| IMAC Holdings, Inc. | 5.19 Million USD | -56254.397% |
| biote Corp. | 185.36 Million USD | -1480.027% |
| Cryo-Cell International, Inc. | 31.34 Million USD | -9243.946% |
| Cross Country Healthcare, Inc. | 2.01 Billion USD | -45.007% |
| COMPASS Pathways plc | - USD | -Infinity% |
| DocGo Inc. | 624.28 Million USD | -369.132% |
| The Ensign Group, Inc. | 3.72 Billion USD | 21.468% |
| Healthcare Services Group, Inc. | 1.67 Billion USD | -75.228% |
| InnovAge Holding Corp. | 763.85 Million USD | -283.415% |
| The Joint Corp. | 117.69 Million USD | -2388.385% |
| LifeStance Health Group, Inc. | 1.05 Billion USD | -177.431% |
| Mobile-health Network Solutions Class A Ordinary Shares | 10.35 Million USD | -28173.719% |
| ModivCare Inc. | 2.75 Billion USD | -6.454% |
| NewGenIvf Group Limited | 5.13 Million USD | -56922.016% |
| Option Care Health, Inc. | 4.3 Billion USD | 31.927% |
| P3 Health Partners Inc. | 1.26 Billion USD | -131.269% |
| P3 Health Partners Inc. | 1.26 Billion USD | -131.269% |
| The Pennant Group, Inc. | 544.89 Million USD | -437.491% |
| Surgery Partners, Inc. | 2.74 Billion USD | -6.76% |
| Syra Health Corp. Class A Common Stock | 5.51 Million USD | -53003.564% |
| Talkspace, Inc. | 150.04 Million USD | -1851.906% |
| Talkspace, Inc. | 150.04 Million USD | -1851.906% |
| The Oncology Institute, Inc. | 324.23 Million USD | -803.265% |
| The Oncology Institute, Inc. | 324.23 Million USD | -803.265% |